LENZ Therapeutics, Inc. (LENZ) — Insider Trading & SEC Form 4 Filings
This page tracks SEC Form 4 insider transactions for LENZ Therapeutics, Inc. (LENZ). Officers, directors, and 10%+ beneficial owners are required to report their LENZ trades to the SEC within two business days.
- 14 recent acquisitions ($675,696)
- 36 recent disposals ($56,714,941)
- 50 filings in this window
Recent LENZ insider transactions
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Mar 27, 2026 | George Jeffrey P. | Director | Buy | 5,592 | $49,890 |
| Mar 27, 2026 | Schimmelpennink Evert B. | Director, Officer | Buy | 28,089 | $251,411 |
| Mar 27, 2026 | Chevallard Daniel R. | Officer | Buy | 7,500 | $64,275 |
| Jan 2, 2026 | Odrich Marc | Officer | Buy | 14,000 | — |
| Jan 2, 2026 | Schimmelpennink Evert B. | Director, Officer | Buy | 358,100 | — |
| Jan 2, 2026 | Odrich Marc | Officer | Buy | 84,200 | — |
| Jan 2, 2026 | Chevallard Daniel R. | Officer | Buy | 84,200 | — |
| Jan 2, 2026 | Olsson Shawn | Officer | Buy | 84,200 | — |
| Jan 2, 2026 | Chevallard Daniel R. | Officer | Buy | 14,000 | — |
| Jan 2, 2026 | Olsson Shawn | Officer | Buy | 14,000 | — |
| Nov 17, 2025 | Olsson Shawn | Officer | Sell | 10,000 | — |
| Nov 17, 2025 | Olsson Shawn | Officer | Sell | 4,212 | $108,417 |
| Nov 17, 2025 | Olsson Shawn | Officer | Buy | 10,000 | $20,800 |
| Nov 17, 2025 | Olsson Shawn | Officer | Sell | 5,788 | $152,630 |
| Nov 7, 2025 | MCCOLLUM JAMES W | Director | Buy | 10,500 | $239,295 |
| Nov 7, 2025 | Chevallard Daniel R. | Officer | Buy | 20 | $454 |
| Nov 7, 2025 | Chevallard Daniel R. | Officer | Buy | 2,178 | $49,571 |
| Sep 30, 2025 | Versant Vantage II GP-GP, LLC | 10%+ | Sell | 34,405 | $1,560,267 |
| Sep 30, 2025 | Versant Vantage II GP-GP, LLC | 10%+ | Sell | 177 | $8,321 |
| Sep 30, 2025 | Versant Vantage II GP-GP, LLC | 10%+ | Sell | 57,502 | $2,668,668 |
Frequently asked questions
- What is insider trading for LENZ?
- Insider trading refers to SEC Form 4 filings by officers, directors, and 10%+ owners of LENZ Therapeutics, Inc.. These are public disclosures of legal transactions — open-market buys, sells, option exercises, and gifts — required within two business days of the trade.
- How many insider transactions has LENZ had recently?
- The most recent 50 insider filings for LENZ are shown below, with 14 acquisitions and 36 disposals in this window. Data is sourced directly from SEC EDGAR.
- Where does this insider data come from?
- All insider data is parsed from original SEC Form 4, Form 3, and Form 5 XML filings on EDGAR. Filings marked as amended or superseded are excluded from summary counts.